The use of melanocortin antagonists in cachexia of chronic disease

Author： Scarlett Jarrad M   Marks Daniel L  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.10, 2005-10, pp. : 1233-1240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melanocortin-4 Receptor Antagonists as Potential Therapeutics in the Treatment of Cachexia

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1131-1136

Bentham Science Publishers

Access to resources Recommend Favorite

Ghrelin is promising for chronic obstructive pulmonary disease (COPD)-associated cachexia

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Use of β-Adrenoceptor Antagonists in Older Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Co-Morbidity: Safety Issues

By Andrus Miranda R.   Loyed Joyce V.  

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 131-144

Adis International

Access to resources Recommend Favorite

The Melanocortin System and its Role in Obesity and Cachexia

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 855-883

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to the rational design of selective melanocortin receptor antagonists

By Hruby Victor J   Cai Minying   Nyberg Joel   Muthu Dhanasekaran  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 543-557

Informa Healthcare

Access to resources Recommend Favorite